154 related articles for article (PubMed ID: 36711294)
1. Interferon signaling and hypercytokinemia-related gene expression in the blood of antidepressant non-responders.
Yamagata H; Tsunedomi R; Kamishikiryo T; Kobayashi A; Seki T; Kobayashi M; Hagiwara K; Yamada N; Chen C; Uchida S; Ogihara H; Hamamoto Y; Okada G; Fuchikami M; Iga JI; Numata S; Kinoshita M; Kato TA; Hashimoto R; Nagano H; Ueno S; Okamoto Y; Ohmori T; Nakagawa S
Heliyon; 2023 Jan; 9(1):e13059. PubMed ID: 36711294
[TBL] [Abstract][Full Text] [Related]
2. Baseline Serum Levels of Beclin-1, but Not Inflammatory Factors, May Predict Antidepressant Treatment Response in Chinese Han Patients With MDD: A Preliminary Study.
He S; Zeng D; Xu F; Zhang J; Zhao N; Wang Q; Shi J; Lin Z; Yu W; Li H
Front Psychiatry; 2019; 10():378. PubMed ID: 31244689
[TBL] [Abstract][Full Text] [Related]
3. Number of risk genotypes is a risk factor for major depressive disorder: a case control study.
Garriock HA; Delgado P; Kling MA; Carpenter LL; Burke M; Burke WJ; Schwartz T; Marangell LB; Husain M; Erickson RP; Moreno FA
Behav Brain Funct; 2006 Jul; 2():24. PubMed ID: 16822313
[TBL] [Abstract][Full Text] [Related]
4. Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants.
Ju C; Fiori LM; Belzeaux R; Theroux JF; Chen GG; Aouabed Z; Blier P; Farzan F; Frey BN; Giacobbe P; Lam RW; Leri F; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Soares CN; Uher R; Li Q; Foster JA; Kennedy SH; Turecki G
Transl Psychiatry; 2019 Oct; 9(1):254. PubMed ID: 31594917
[TBL] [Abstract][Full Text] [Related]
5. Gene expression and proliferation biomarkers for antidepressant treatment resistance.
Breitfeld J; Scholl C; Steffens M; Laje G; Stingl JC
Transl Psychiatry; 2017 Mar; 7(3):e1061. PubMed ID: 28291260
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling to predict and assess the consequences of therapy-induced virus eradication in chronic hepatitis C virus infection.
Hou J; van Oord G; Groothuismink ZM; Claassen MA; Kreefft K; Zaaraoui-Boutahar F; van IJcken WF; Osterhaus AD; Janssen HL; Andeweg AC; de Knegt RJ; Boonstra A
J Virol; 2014 Nov; 88(21):12254-64. PubMed ID: 25100847
[TBL] [Abstract][Full Text] [Related]
7. Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response.
Fiori LM; Orri M; Aouabed Z; Théroux JF; Lin R; Nagy C; Frey BN; Lam RW; MacQueen GM; Milev R; Müller DJ; Parikh SV; Rotzinger S; Uher R; Foster JA; Kennedy SH; Turecki G
Transl Psychiatry; 2021 Aug; 11(1):439. PubMed ID: 34420030
[TBL] [Abstract][Full Text] [Related]
8. Prediction of therapeutic responses to tocilizumab in patients with rheumatoid arthritis: biomarkers identified by analysis of gene expression in peripheral blood mononuclear cells using genome-wide DNA microarray.
Sanayama Y; Ikeda K; Saito Y; Kagami S; Yamagata M; Furuta S; Kashiwakuma D; Iwamoto I; Umibe T; Nawata Y; Matsumura R; Sugiyama T; Sueishi M; Hiraguri M; Nonaka K; Ohara O; Nakajima H
Arthritis Rheumatol; 2014 Jun; 66(6):1421-31. PubMed ID: 24591094
[TBL] [Abstract][Full Text] [Related]
9. Whole-genome expression analysis reveals genes associated with treatment response to escitalopram in major depression.
Pettai K; Milani L; Tammiste A; Võsa U; Kolde R; Eller T; Nutt D; Metspalu A; Maron E
Eur Neuropsychopharmacol; 2016 Sep; 26(9):1475-1483. PubMed ID: 27461515
[TBL] [Abstract][Full Text] [Related]
10. Citalopram-induced pathways regulation and tentative treatment-outcome-predicting biomarkers in lymphoblastoid cell lines from depression patients.
Barakat AK; Scholl C; Steffens M; Brandenburg K; Ising M; Lucae S; Holsboer F; Laje G; Kalayda GV; Jaehde U; Stingl JC
Transl Psychiatry; 2020 Jul; 10(1):210. PubMed ID: 32612257
[TBL] [Abstract][Full Text] [Related]
11. Predicting Neuroimaging Biomarkers for Antidepressant Selection in Early Treatment of Depression.
Xue L; Pei C; Wang X; Wang H; Tian S; Yao Z; Lu Q
J Magn Reson Imaging; 2021 Aug; 54(2):551-559. PubMed ID: 33634921
[TBL] [Abstract][Full Text] [Related]
12. Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C.
Asselah T; Bieche I; Narguet S; Sabbagh A; Laurendeau I; Ripault MP; Boyer N; Martinot-Peignoux M; Valla D; Vidaud M; Marcellin P
Gut; 2008 Apr; 57(4):516-24. PubMed ID: 17895355
[TBL] [Abstract][Full Text] [Related]
13. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
Raterman HG; Vosslamber S; de Ridder S; Nurmohamed MT; Lems WF; Boers M; van de Wiel M; Dijkmans BA; Verweij CL; Voskuyl AE
Arthritis Res Ther; 2012 Apr; 14(2):R95. PubMed ID: 22540992
[TBL] [Abstract][Full Text] [Related]
14. Biological profiling of prospective antidepressant response in major depressive disorder: Associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity.
Mocking RJT; Nap TS; Westerink AM; Assies J; Vaz FM; Koeter MWJ; Ruhé HG; Schene AH
Psychoneuroendocrinology; 2017 May; 79():84-92. PubMed ID: 28262603
[TBL] [Abstract][Full Text] [Related]
15. Common genes associated with antidepressant response in mouse and man identify key role of glucocorticoid receptor sensitivity.
Carrillo-Roa T; Labermaier C; Weber P; Herzog DP; Lareau C; Santarelli S; Wagner KV; Rex-Haffner M; Harbich D; Scharf SH; Nemeroff CB; Dunlop BW; Craighead WE; Mayberg HS; Schmidt MV; Uhr M; Holsboer F; Sillaber I; Binder EB; Müller MB
PLoS Biol; 2017 Dec; 15(12):e2002690. PubMed ID: 29283992
[TBL] [Abstract][Full Text] [Related]
16. A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers.
Lin E; Kuo PH; Liu YL; Yu YW; Yang AC; Tsai SJ
Front Psychiatry; 2018; 9():290. PubMed ID: 30034349
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for people with epilepsy and depression.
Maguire MJ; Weston J; Singh J; Marson AG
Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response - Systematic review.
Fischer S; Gardini ES; Haas F; Cleare AJ
Neurosci Biobehav Rev; 2019 Jan; 96():182-196. PubMed ID: 30465786
[TBL] [Abstract][Full Text] [Related]
19. Abnormal C-reactive protein blood levels as a specific biomarker of major depression and non-remission under antidepressants in schizophrenia.
Fond G; Micoulaud-Franchi JA; Faugere M; Boyer L; Faget-Agius C; Lançon C; Richieri R; Cermolacce M
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Mar; 97():109800. PubMed ID: 31676465
[TBL] [Abstract][Full Text] [Related]
20. Amygdala Reactivity to Emotional Faces in the Prediction of General and Medication-Specific Responses to Antidepressant Treatment in the Randomized iSPOT-D Trial.
Williams LM; Korgaonkar MS; Song YC; Paton R; Eagles S; Goldstein-Piekarski A; Grieve SM; Harris AW; Usherwood T; Etkin A
Neuropsychopharmacology; 2015 Sep; 40(10):2398-408. PubMed ID: 25824424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
